Evidence map›Paper›PMID 18697849›Full record

ArticleClinical trials (London, England)2008

The Hip Impact Protection Project: design and methods.

Bruce A Barton, Stanley J Birge, Jay Magaziner, Sheryl Zimmerman, Linda Ball, Kathleen M Brown, Douglas P Kiel

Abstract read
In one paragraph

Article in Clinical trials (London, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Hip protectors for preventing hip fractures in older people.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Sample size verification for clinical trials.Clinical and translational science · 2014
    Article
  3. Emergency orthogeriatrics: concepts and therapeutic alternatives.Emergency medicine clinics of North America · 2010
    Review
  4. Article
  5. Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II).Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Bruce A BartonMaryland Medical Research Institute, Baltimore, MD, USA. bbarton@mmri.org
Stanley J Birge
Jay Magaziner
Sheryl Zimmerman
Linda Ball
Kathleen M Brown
Douglas P Kiel
Maryland Medical Research Institute · USWashington University in St. Louis · USHebrew SeniorLife · USUniversity of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · US

Funding

Trochanteric Padding to Prevent Hip FracturesR01AG018461 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI KIEL, DOUGLAS P. · 2001 to 2005
$8.6M
NIA NIH HHS R01 AG018461
6 · The paper itself

Abstract

backgroundNearly 340,000 hip fractures occur each year in the U.S. With current demographic trends, the number of hip fractures is expected to double at least in the next 40 years. PURPOSE: The Hip Impact Protection Project (HIP PRO) was designed to investigate the efficacy and safety of hip protectors in an elderly nursing home population. This paper describes the innovative clustered matched-pair research design used in HIP PRO to overcome the inherent limitations of clustered randomization.

methodsThree clinical centers recruited 37 nursing homes to participate in HIP PRO. They were randomized so that the participating residents in that home received hip protectors for either the right or left hip. Informed consent was obtained from either the resident or the resident's responsible party. The target sample size was 580 residents with replacement if they dropped out, had a hip fracture, or died. One of the advantages of the HIP PRO study design was that each resident was his/her own case and control, eliminating imbalances, and there was no confusion over which residents wore pads (or on which hip). LIMITATIONS: Generalizability of the findings may be limited. Adherence was higher in this study than in other studies because of: (1) the use of a run-in period, (2) staff incentives, and (3) the frequency of adherence assessments. The use of a single pad is not analogous to pad use in the real world and may have caused unanticipated changes in behavior. Fall assessment was not feasible, limiting the ability to analyze fractures as a function of falls. Finally, hip protector designs continue to evolve so that the results generated using this pad may not be applicable to other pad designs. However, information about factors related to adherence will be useful for future studies.

conclusionsThe clustered matched-pair study design avoided the major problem with previous cluster-randomized investigations of this question - unbalanced risk factors between the experimental group and the control group. Because each resident served as his/her own control, the effects of unbalanced risk factors on treatment effect were virtually eliminated. In addition, the use of frequent adherence assessments allowed us to study the effect of various demographic and environmental factors on adherence, which was vital for the assessment of efficacy.

Indexed as

Research DesignAgedGuideline AdherenceHip FracturesHomes for the AgedHumansMatched-Pair AnalysisMulticenter Studies as TopicNursing HomesProtective DevicesSafety Management

Identifiers

PMID18697849
PMCPMC3725461
OpenAlexW2135090721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.